Mouth Dissolving Tablet: A
Formulation Approach
Bhagat B.V., Hapse S.A., Jadhav A.P., Gawand R.B.
Dr.V.V.P.Fs College of
Pharmacy, Vilad Ghat,
Ahmednagar (MH)
*Corresponding Author
E-mail: babasahebbhagat@gmail.com
ABSTRACT:
Fast
dissolving tablet are the novel dosage form which is well accepted now a days
by geriatric and pediatric patients because it does not need water to swallow.
The aim of the present article is to study the natural polymers and the
formulation approach of mouth dissolving tablets. MDTs are solid dosage forms
containing medicinal substances which disintegrate rapidly, usually in a matter
of seconds, when placed on the mouth. New MDT technologies address many
pharmaceutical and patient needs ranging from enhanced life-cycle management to
convenient dosing for pediatric, geriatric, and psychiatric patients with dysphagia. This has encouraged both academia and industry
to generate new orally disintegrating formulations and technological approaches
in this field. The aim of this article is to review the development of MDTs,
challenges in formulation, new MDT technologies, evaluation methodologies,
suitability of drug candidates, and future prospects.
KEYWORDS: Mouth
Dissolving Tablets (MDTs), MDT Technology, Superdisintegrants.
INTRODUCTION:
For most
therapeutic agents used to produce systemic effects, the oral route still
represents the preferred way of administration owing to its several advantages
and high patient compliance compared to many other routes. Tablets constitute a
major portion of drug delivery systems that are currently available. However,
many patient groups such as the elderly, children and patients who are mentally
retarded, uncooperative, nauseated or on reduced liquid-intake/diets have
difficulties swallowing these dosage forms. Those who are traveling or have
little access to water are similarly affected. To fulfill these medical needs,
pharmaceutical technologists have developed a novel oral dosage form known as
Mouth Dissolving Tablets (MDTs) which disintegrate rapidly in saliva, usually
in a matter of seconds, without the need to take water. Drug dissolution and
absorption as well as onset of clinical effect and drug bioavailability may be
significantly greater than those observed from conventional dosage forms. 6,7,8,20
Ideal
Properties of MDTs: 1,5
1. A MDT should be dissolve in the mouth (i.e.
in saliva) within seconds.
2. For its action, it should not require water
or any liquid.
3. It has a pleasant mouth feeling.
4. Be compatible with taste masking and
portable without fragility concern.
5. It should have high wet ability of
recipients.
6. It should not have residue in the mouth
after administration of the tablet.
7. The environmental conditions like the
humidity and temperature have less effect on it.
8. It has more rapid absorption of the drug
from pre-gastric.
9. The processing and packaging equipments
have low cost.
10. Allow high loading of the drug.
11. The tablet structure should have a highly
porous network area which tends to rapid onset of action.
Advantages of MDT: 3,5
1. No need of water.
2. Better taste.
3. No chewing needed.
4. Improved stability.
5. Allows high drug loading.
6. Sustained release action.
7. Low
Cost production.
8. Rapid drug therapy intervention.
9. High loading of drug is possible.
10. Have pleasant taste and minimum residue.
Disadvantages
of MDT: 1,5
1. Soluble diluents used for formulating MDTs
may render hygroscopic dosage which may lead to stability issues.
2. The tablets may give unpleasant taste.
3. It may require specialized packing for
hygroscopic and light sensitive drugs.
4. Precautions to be taken while administering
immediately after removing from pack.
The need
for Development of MDT:
1) Patient Factors:
Orally
disintegrating dosage forms are particularly suitable for patients, who
inconvenient to swallow traditional tablets and capsules with a glass of water.
And also for those who undergoes radiation therapy, unwilling to take solid
preparation. 1,3
2) Effectiveness Factor:
Increased
bioavailability and faster onset of action are a major claim of these
formulations. Dispersion in saliva in oral cavity causes pregastric
absorption. 3
3) Manufacturing and Marketing Factors:
Developing
new drug delivery technologies and utilizing them in product development is
critical for pharmaceutical industries to survive, regardless of their size. A
new dosage form allows a manufacturer to extend market exclusivity, unique
product differentiation, value-added product line extension, and extend patent
protection, while offering its patient population a more convenient dosage
form. This enhances revenue. 1,3
Challenges
in Formulating MDT:
1) Palatability:
As most
drugs are unpalatable, Mouth dissolving drug delivery systems usually contain
the medicament in a taste-masked form. Delivery systems disintegrate or
dissolve in patient’s oral cavity, thus releasing the active ingredients which
come in contact with the taste buds; hence, taste-masking of the drugs becomes
critical to patient compliance. 5,6
2) Mechanical Strength:
In order to
allow MDTs to disintegrate in the oral cavity, they are made of either very
porous and soft-molded compressed into tablets with very low compression force,
which makes the tablets friable and/or brittle, difficult to handle, and often
requiring specialized packing that may add to the cost. 1,5
3) Hygroscopicity:
Several
orally MDTs dosage forms are hygroscopic and cannot maintain physical integrity
under normal conditions of temperature and humidity. Hence, they need
protection from humidity. 5,6
4) Amount of Drug:
The
application of technologies used for MDTs is limited by the amount of drug that
can be incorporated into each unit dose. This parameter is particularly
challenging when formulating a fast-dissolving oral films or wafers. 1,5,6
5) Aqueous Solubility:
Water-soluble
drugs pose various formulation challenges because they form eutectic mixtures,
which result in freezing-point depression and the formation of a glassy solid
that may collapse upon drying because of loss of supporting structure during
the sublimation process. 5,6
6) Size
of Tablet:
The degree
of ease when taking a tablet depends on its size. It has been reported that the
easiest size of tablet to swallow is 7-8 mm while the easiest size to handle
was one larger than 8 mm. Therefore, the tablet size that is both easy to take
and easy to handle is difficult to achieve. 1,6
Formulation
Technologies6,8:
Conventional
Technologies |
Patented
Technologies |
Freeze drying |
Zydus technology |
Sublimation |
Orasolv technology |
Spray drying |
Durasolv technology |
Moulding |
Wowtab technology |
Mass extrusion |
Flashdose technology |
Direct
compression |
Flashtab technology |
Cotton candy
process |
Oraquick technology |
A) Conventional
Technologies :
1) Freeze
Drying or Lyophilization:
A process, in which water is sublimated
from the product after freezing, is called freeze drying. Freeze drying process
is one of the first generations of fast disintegrating dosage form. Freeze
dried forms offer more rapid dissolution than other available solid products. 4,6
Ø
Advantage:
Pharmaceutical substances can
be processed at non elevated temperature, thereby eliminating adverse thermal
effects.
Ø Disadvantage:
a. Due to high cost of equipments, Lyophilization is relatively expensive and time consuming.
b. Fragility, which make the poor stability
during storage under stressful condition.
2) Sublimation:
Porous tablets that exhibit good mechanical
strength and dissolve quickly have been developed in this process. Inert solid
ingredients were added to other tablet excipients and
the blend was compressed into tablet. Sublimation generated a porous structure.
The tablets dissolve within 10-20 seconds. 6,7
3) Spray Drying:
Spray drying can be used to prepare rapidly
dissolving tablets. This technique is based upon a particulate support matrix
that is prepared by spray drying an aqueous composition containing support
matrix and other components to form a highly porous and fine powder. This is
then mixed with active ingredient and compressed into tablet. 1,4
4) Moulding:
Tablets produced by moulding
are solid dispersions. Physical form of the drug in the tablets depends whether
and to what extent it dissolves in the molten carrier. The drug can exist as
discrete particles or micro particles dispersed in the matrix. It can dissolve
totally in the molten carrier to form solid solution. 1,4,6
Ø Advantage:
a. Moulded tablets possess porous structure, which
facilitates rapid disintegration.
b. Moulded tablets improve taste due to water-soluble
sugars present in dispersion matrix.
Ø Disadvantage:
a. Moulded tablets lack good mechanical strength and
can undergo breakage during handling and opening of blister packs
5) Mass Extrusion:
This technology involves softening the
active blend using the solvent mixture of water soluble polyethylene glycol,
using methanol and expulsion of softened mass through the extruder or syringe
to get a cylinder of the product into even segments using heated blade to form
tablets. The dried cylinder can also be used to coat granules of bitter tasting
drugs and thereby making their bitter taste. 1,7
6)
Direct Compression:
The direct compression is the most
preferred technique to manufacture the tablets. MDTs can be fabricated using
conventional tablet manufacturing and packaging machinery and also due to
availability of tabulating excipients with improved
flow, compressibility and disintegration properties, especially tablet
disintegrates, effervescent agents and sugar based excipients.
1,6
Ø Advantage:
a. High doses can be accommodated.
b. Easiest way to manufacture the MDT tablets.
c. Conventional equipment and commonly
available excipients are used.
d. A limited number of processing steps are
involved.
e. Cost-effectiveness.
7)
Cotton-Candy Process:
This technology use to eliminate the bitter
taste of the medicament .The Shear form technology is employed in the
preparation of a matrix known as ‘floss’, made from a combination of excipients, either alone or with drugs. The floss is a
fibrous material similar to cotton-candy fibers, commonly made of saccharides such as dextrose, sucrose, lactose and fructose
at temperatures ranging between 180–266 °F. 1,6,7
8) Nanonization:
A recently developed Nanomelt
technology involves reduction in the particle size of drug to nanosize by milling the drug using a proprietary
wet-milling technique. The nano crystals of the drug
are stabilized against agglomeration by surface adsorption on selected
stabilizers, which are then incorporated into MDTs. This method is advantageous
for poorly water soluble drugs. 1,7
9) Fast
Dissolving Films (Solvent Casting):
In this
technique, a non-aqueous solution is prepared containing water soluble film
forming Polymers i.e. carboxy methylcellulose, hydroxypropyl methylcellulose, hydroxyl ethyl cellulose,
drug and other taste masking ingredients, which is allowed to form a film after
evaporation of solvents. This film, when placed in mouth, melts or dissolves
rapidly, releasing the drug in solution or suspension form. 1,6,7
10) Melt
Granulation:
Super polystate incorporated in the formulation of ODT by melt
granulation method where granules are formed by the molten form of this material.
Super Polystate is a waxy material with have melting
point of 33-37C. It acts as a binder, Increases the physical resistance of
tablets, also helps in disintegration of tablets and solubilizes
rapidly leaving no residue. 4,6
Ø Advantages:
a. Neither solvent nor water used in this
process.
b. Uniform dispersion of fine particle occurs.
c. Good stability at varying pH and moisture
levels.
d. Fewer processing steps needed thus time
consuming drying steps eliminated.
Ø Disadvantages:
a.
Requires
high energy input.
b.
It cannot
suitable for heat-sensitive materials.
c.
Higher-melting-point
binders require high melting temperatures.
Comparison of Technologies: 1,6,7
Technology |
Advantages |
Disadvantages |
Freeze drying |
Immediate dissolution (2-10 s) |
Very poor physical resistance, high cost of production, sensitive to
humidity. |
Tableting (sublimation) |
Good physical resistance |
Extra equipments for heating, not applicable to volatile and heat
sensitive drugs. |
Molding |
Very rapid dissolution (5–15 s) High dose |
High cost of production, Weak mechanical strength, possible
limitations in stability. |
Tableting (standard) |
Low cost of production,
high dose ,good physical resistance |
Significant effects of the size and hardness of the tablets on
disintegration property. |
Tableting (effervescent) |
Good physical resistance,
pleasant effervescent mouths feel. |
Operating in controlled low humidity need of totally impermeable
blister |
Tableting(Humidity treatment) |
Good physical resistance, pleasant mouth feels. |
Extra equipments for Drying, limitations in stability, high cost of
production. |
(B) Patented
Technologies:
1) Zydis Technology:
Zydis
formulation is a unique freeze dried tablet. In this drug is dissolved within
the matrix of fast-dissolving carrier material. When formulation is put into
the mouth, the freeze dried structure disintegrates instantaneously and does
not require water to aid swallowing. The Zydis matrix
is composed of many materials such as Dextran, Sorbitol/ Mannitol, Gelatin,
Water, various gums, Glycine etc. 1,7
Ø Advantages:
a. They are self-preserving formulation.
b. Suitable for pediatric patients
c. Avoids first-pass metabolism
Ø Disadvantages:
a. Expensive manufacturing process.
b. Poor stability at higher and humidities and temperature.
c. The freeze-drying is time consuming
process.
2) OraSolv Technology:
This
technology is patented by CIMA Labs. This includes use of effervescent
disintegrating agents compressed with low pressure to produce the MDTs. It
involves blending the microencapsulated API with magnesium oxide and mannitol to aid in the release of the drug from the
polymeric coating. Tablets are compressed to a hardness of 6-25 N and packaged
in blister cards. On contact with saliva, the effervescent system promotes
disintegration of the tablet. Carbon dioxide is generated by a reaction of the
formulation components with saliva in the mouth. 1,6
Ø Advantages:
a. Applicable for drug strengths in the range
of 1 mg to 750 mg.
b. PakSolvR is a “dome-shaped” blister package that
prevents the vertical movement of the tablet within the depressions.
c. PakSolvR also offers light, moisture, and child
resistance.
Ø Disadvantages:
a.
Both OraSolv and DuraSolv products are
sensitive to moisture due to the presence of the effervescent system and must
be packaged appropriately.
3) DuraSolv Technology:
This technology
has a formulation similar to the OraSolv technology,
combining taste masked drug micro particles containing formulation, was
developed by CIMA labs, consist of a drug, fillers and the lubricants. The
tablets are prepared by conventional tab letting equipment and have good
rigidity. 1,6,7
Ø Advantages:
a. DuraSolv technology is good for tablets having low
amount (125 mcg to 500 mg) of active ingredients.
b. This
technology enables packaging flexibility; tablets can be bottled and blistered.
Ø Disadvantages:
a.
The
technology is not suitable for larger doses of active ingredients.
4) Wow tab Technology:
Yamanauchi
pharmaceutical company patented this technology. ‘wow’ means ‘without water’.
WOWTAB means the tablet is to be given without water. The active ingredients
may constitute up to 50% w/w of the tablet. In this technique, Saccharides of both low and high mould ability are used to
prepare the granules. This technology utilizes sugar-like excipients.
1,7
Ø Advantages:
a. Dissolves quickly in 15 seconds or less.
b. Can be packed in both into conventional
bottle and blister packs.
5) Flash
Dose Technology:
This
technology is patented by Fuisz. This system uses the
combination of both Shearform and Ceform
technologies are helpful in order to mask the bitter taste of the drug. A sugar
based matrix, called ‘Floss’ is used. 1,6,7
Ø Disadvantages:
a. Can accommodate only up to 600 mg of drug.
b. Specialized packing of tablets is required.
6) Flashtab Technology:
Prographarm
laboratory have a patent over this technology. In this technology, microgranules of the taste-masked active drug are used.
These may be prepared by using conventional techniques like coacervation,
microencapsulation, simple pan coating methods and extrusion-spheronisation. 1,6
7) Oraquick Technology:
K. V. S. Pharmaceuticals
have a patent over this technology. It utilizes taste masking microsphere
technology called as micromask, which provides
superior mouth feel over taste masking alternatives, significant mechanical
strength, and quick dissolving of product.
1,7
8) Pharmaburst Technology:
SPI Pharma, New Castle has a patent over this technology. It
utilizes the co-processed excipients to develop MDTs,
which dissolves within 30-40 seconds. This technology involves dry blending of
drug, flavour, and lubricant followed by compression
into tablets.6,7
9) Nanocrystal Technology:
Elan, King of
Prussia has a patent over this technology. This technology includes Nanocrystal colloidal dispersions of drug substance are
combined with water-soluble GRAS (Generally Regarded as Safe) ingredients,
filled into blisters, and lyophilized. The resultant wafers are remarkably
robust, yet dissolve in very small quantities of water in seconds. This method
avoids manufacturing process such as granulation, blending, and tab letting. 1,7
Ø Advantages:
a. Highly potent and hazardous drugs are
mostly used.
b. Useful for manufacturing small quantities of
drugs.
c. Manufacturing losses are less or
negligible.
d. Wide range of doses (up to 200 mg of API
per unit).
10) Frosta
Technology:
A new technology called Frosta
(Akina) was developed for making FMTs. The technology
utilizes the conventional wet granulation process and tablet press for
cost-effective production of tablets.
The Frosta tablets are mechanically strong
with friability of less than 1% and are stable in accelerated stability
conditions .Frosta tablets can melt in less than 10
seconds in the oral cavity.1,6
Criteria
for Drug Selection: 3,6
The ideal
characteristics of a drug for mouth dissolving tablet include:
1) Drug
should have good stability in Water and saliva.
2) Drug has
ability to permeate the oral mucosa.
3) Drug has
pleasant taste.
4) Have the
ability to diffuse and partition into the epithelium of the upper GIT
5) Small to
moderate molecular weight.
6) Low dose
drugs preferably less than 50mg.
7) Short
half life and frequent dosing drugs are unsuitable for MDT.
Excipients used in MDT’s preparation: 6,9
Name of the Excipients |
% used |
Superdisintegrant |
1-15% |
Binders |
5-10% |
Antistatic agent |
0-10% |
Diluents |
0-85% |
Superdisintegrant |
Example |
Mechanism
Of action |
Crosscarmellose, Ac-Di-Sol, Nymce ZSX, VivasolRL-HPC |
Crosslinked Cellulose |
Swells 4-8 folds in LT 10
seconds. Swelling and wicking both. |
Sodium starch , glycolate, Explotab |
Cross linked Starch |
-Swells 7-12 folds in < 30 seconds. |
Soy polysaccharides, Emcosoy |
Natural super disintegrate |
- |
Crosspovidon M, Kollidon, Polyplasdone |
Cross linked PVP |
Swells very little and
returns to original size after compression but act by capillary action. |
1)
Super Disintegrants:
Superdisintegrant are playing major role in MDT. Which are
effective at low concentrations. They have greater disintegrating efficiency
and they are more effective intra granularly. This superdisintegrants
act by swelling and causes tablet to accelerated absorption of water leading to
an enormous increase in the volume of granules to promote disintegration. 4,9
2) Bulking Materials:
Bulking
materials contributes functions of a diluents, filler and cost reducer. Bulking
agents improve the textural characteristics. It enhances the disintegration in
the mouth. The material such as mannitol, polydextrose, lactitol, direct
compressible lactose and starch hydrolystate are
added in the range of 10-90% by weight of the final composition. 6,9
3) Lubricants:
Lubricants
remove grittiness and assist in the drug transport mechanism from the mouth
down into the stomach. 6
4) Taste
Masking:
Taste
masking achieved by flavoring and perfuming agents. It can be obtained from
either natural or synthetic origin. Natural products include fruit juices,
aromatic oils like peppermint and lemon oils, herbs, spices, and distilled
fractions of these. Apart from these many compositions are showing effective
taste-masking abilities with improved flavor such as alkaline earth oxide,
alkaline earth hydroxide, or an alkaline hydroxide.9
5) Emulsifying
Agent:
Emulsifying
agents give rapid disintegration and drug release without chewing, swallowing
or drinking water. They are useful in stabilizing the immiscible blends and
enhancing bioavailability. A wide range of emulsifiers including alkyl
sulfates, propylene glycol esters and lecithin is used in wide range. These
agents can be added in the range of 0.05-15% by weight of the final
composition. These dosage forms may be suitable for the oral delivery of drugs.
4,6
MDT
products in Indian market: 1,2
S. No. |
Brand Name |
Active Ingredients |
Company |
1 |
Nimulid-MD |
Nimesulide |
Panacea |
2 |
Biotech Zyrofmeltab |
Rofecoxib |
Zydus Cadila |
3 |
Valus |
Valdecoxib |
Glenmark |
4 |
Olanexinstab |
Olanzepine |
Ranbaxy |
5 |
Manza BDT |
Olanzepine |
Orchid |
6 |
Remeron Sol Tab |
Mirtazapine |
Organon |
Evaluation
of MDT:
1) Hardness/Crushing
Strength:
It is
measured using conventional hardness testers. A significant strength of ODT is
difficult to achieve due to the specialized processes and ingredients used in
the manufacturing. The limit of crushing strength for an ODT must be in a lower
range to facilitate early disintegration in the mouth. 3,4
2) Friability:
All methods
of manufacturing of ODT are responsible for increasing the % friability values.
Thus, it is necessary that this parameter should be evaluated and the results
are within bound limits (0.1-0.9%). To achieve % friability within limits for
an ODT is a challenge to the formulator. 3,4,6
3) Wetting
Time:
Wetting
time of dosage form is related with the contact angle. The wetting time of the
tablets can be measured using a simple procedure; five circular tissue papers
of 10 cm diameter are placed in a petridish with a 10
cm diameter. Ten milliliters of water-soluble dye (eosin) solution is added to petridish. A tablet is carefully placed on the surface of
the tissue paper. The time required for water to reach upper surface of the
tablet is noted as the wetting time. 3,4
4) Moisture
Uptake Studies:
A moisture uptake study for ODT is useful for
stability of the formulation. Ten tablets from each formulation were kept in a desiccators
over calcium chloride at 37°C for 24 h. The tablets were then weighed and
exposed to 75% relative humidity, at room temperature for 2 weeks. Required
humidity was achieved by keeping saturated sodium chloride solution at the
bottom of the desiccators for 3 days. One tablet as control (without superdisintegrant) was kept to assess the moisture uptake
due to other excipients. Tablets were weighed and the
percentage increase in weight was recorded. 4,6
5) Disintegration
Test:
The
disintegration test for MDT should mimic disintegration in mouth with in
salivary contents. The time for disintegration of ODTs is generally <1 min
and actual disintegration time, that patient can experience ranges from 5 to 30
s. The standard procedure of performing disintegration test has several
limitations and it is not suitable to measurement very short disintegration
times.3,6
6) Dissolution
Test:
Dissolution
conditions for drugs listed in a pharmacopoeia monograph, is a good place to
start with scouting runs for a bioequivalent ODT. USP dissolution apparatus 1
and 2 can be used. Kancke proposed USP 2 Paddle
apparatus, which is the most suitable and common choice for MTDs, with a paddle
speed of 50 rpm commonly used. The USP 2 Paddle apparatus at 50-100 rpm is
suitable for dissolution testing of taste-masked drug as well. 4
Future Prospects:
Therapeutics
that has limited bioavailability when administered by conventional tablets, these
products usually degrade rapidly in the stomach. Should next generation drugs
are predominantly protein or peptide based, tablets may no longer be the
dominant format for dosing such moieties. Injections generally are not favored
for use by patients unless facilitated by sophisticate auto injectors.
Inhalation is one good alternative system to deliver these drugs, but the
increased research into biopharmaceuticals so far has generated predominantly
chemical entities with low molecular weights. The developments of enhanced oral
protein delivery technology by MDTs which may release these drugs in the oral
cavity are very promising for the delivery of high molecular weight protein and
peptide. 3,5
CONCLUSION:
Mouth
dissolving tablets (MDTs) are innovative drug delivery systems and have
potential advantages over conventional dosage forms, with their improved
patient compliance, convenience, bioavailability and rapid onset of action.
Though considerable research has been done in the formulation, development and
technologies for MDTs, more intensive investigations are to be carried out in
this promising area to result in newer cost effective technologies and better
product. 3,4
REFERENCE:
1. Ajoy Bera and Ashish Mukherjee, A Detailed Study of Mouth Dissolving Drug Delivery System, Acta
Chimica Pharmaceutics Indica,
2013; 3(1), 65-93.
2. Sunitha H.S., Asian
Journal of Research in Pharmaceutical Sciences and Biotechnology, 2(2), 2014,
31 – 37.
3. Jaysukh J Hirani 1 , Dhaval A Rathod, Kantilal R Vadalia, Orally Disintegrating Tablets: A Review, Tropical
Journal of Pharmaceutical Research, April 2009; 8 (2), 161-172.
4. K.P.R. Chowdary, K.Ravi Shankar and B. Suchitra, Recent Research on Orodispersible Tablets : A
Review, Int. Res J Pharm. App Sci., 2014; 4(1), 64-73.
5. Abay FB and Ugurlu T, Orally Disintegrating Tablets: A Short Review,
Journal of Pharmaceutics & Drug Development, Vol.3, June 25, 2015.
6. Rewar S, Singh CJ, Oral
Dispersible Tablets: An Overview; Development, Technologies And Evaluation,
International Journal of Research and Development in Pharmacy and Life
Sciences, Oct-Nov 2014, Vol. 3,1223-1235.
7. K. B. Deshpande, Orodispersible Tablets: An Overview of Formulation and Technology,
International Journal of Pharma and Bio Sciences,
Vol. 2, Jan-Mar 2011, 726-734.
8. US Food and Drug
Administration, CDER Data Standards
Manual.2003.http://www.fda.gov/cder/dsm/DRG/drg00201.htm. Accessed 6 February
2007.
9. P. Venkateshwar Reddy et al / Int. J. of Pharmacy and Analytical Research Vol-3(1) 2014
[22-29].
10. J. A. Fix Advances
in Quick-Dissolving Tablets Technology Employing Wow tab’ Paper Presented at:
IIR Conference on Drug Delivery Systems, Oct.; Washington DC, USA (1998).
11. WWW.
ElanNanoCrystal_Technology.html.
12. R. Panigrahi and S. Behera, A Review
on Fast Dissolving Tablets, Webmed Central Quality
and Patient Safety, 1(9), 1-15 (2010).
13. Velmurugan S and Sundar Vinushitha. Oral
Disintegrating Tablets: An Overview, IJCPS,1(2),
2010, 1-12.
14. Dobetti L. Fast
disintegrating tablets. US Patent 2003; 6:596,311.
15. Van Scoik KG. Solid Pharmaceutical dosage in tablet triturates
form and method of producing the same. US Patent 5,082,667.
16. Dobetti L. (Eurand International), Fast Disintegrating tablets, PCT
Patent WO 99/44580-A1; 1992.
17. Mallet L, Caring
for the Elderly Patient. J. Am. Pharm. Assoc, 36 (11): 628-635, (1996).
18. Deepak K, Orally
disintegrating tablets. Tablets and Capsules 7: 30-35, (2004).
19. European
Directorate for quality of Medicines. Pharmaeuropa.10 (4): 547,
(1998)http://www.pheur.org. Accessed 6 February 2007.
20. Makino, T, Fast
dissolving tablet and its production, US patent, 1998, 5,720,974.
Received on 06.10.2016
Modified on 09.11.2016
Accepted on 06.12.2016 ©
RJPT All right reserved
Research J. Pharm. and Tech. 2017; 10(1):
355-361.
DOI: 10.5958/0974-360X.2017.00072.5